Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults.
about
A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skinSkin rejuvenation with non-invasive pulsed electric fieldsDNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response.Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation.In vivo molecular imaging and histological analysis of changes induced by electric pulses used for plasmid DNA electrotransfer to the skin: a study in a dorsal window chamber in mice.Nanosecond electric pulse effects on gene expressionTolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers.Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation DeviceCharacterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.Electroporation-enhanced delivery of nucleic acid vaccines.Clinical potential of electroporation for gene therapy and DNA vaccine delivery.Enhanced Delivery of DNA or RNA Vaccines by Electroporation.Immunogenicity and safety of xenogeneic vascular endothelial growth factor receptor-2 DNA vaccination in mice and dogs.Adipose tissue: a new target for electroporation-enhanced DNA vaccines.What is the antiallergic potential of DNA vaccination?A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
P2860
Q33723334-01C0E186-DA5E-4E78-B75D-262597106D47Q35595565-7637CE57-E26A-4F53-BDF0-7A5AFD2D272EQ35655963-2176F82A-F129-4F85-BF1C-A24E789B5A0FQ35826661-20DADCB8-C4B2-40A3-A86D-DE4B0774E86AQ36297880-91FC567D-EBA5-4D79-9E21-876A802E2D90Q37301001-535E212B-23C2-495F-A341-A716818E13E9Q37530540-74954BEE-7852-4AE6-B391-F69CDA5E4795Q37550619-838AE23E-0AF1-4D8F-AB05-6C9FE734DC45Q37573037-DBB4618E-6046-4AF9-8E69-F8B36E6BCE89Q38285418-AEE2939D-3AAD-438C-A46D-BAC682B37316Q38636510-D975F94F-CA31-4123-A464-69C25FE1C7B6Q40420214-D35E0174-3B65-49B7-A661-077A8B299262Q42576477-4D462F94-9F40-49C7-BAE4-DD7FB448C7E4Q45874005-04D6BD02-9CDC-4233-AE02-4D20CFBD33EFQ48027406-D71AA1AA-1788-4CDD-9483-2613C6402ADDQ53272516-DAFD5183-2229-4CF7-BE9E-17355C4183F2
P2860
Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Safety and tolerability of the ...... tion system in healthy adults.
@ast
Safety and tolerability of the ...... tion system in healthy adults.
@en
type
label
Safety and tolerability of the ...... tion system in healthy adults.
@ast
Safety and tolerability of the ...... tion system in healthy adults.
@en
prefLabel
Safety and tolerability of the ...... tion system in healthy adults.
@ast
Safety and tolerability of the ...... tion system in healthy adults.
@en
P2093
P2860
P356
P1433
P1476
Safety and tolerability of the ...... tion system in healthy adults.
@en
P2093
Albert Lee
Elaina Colby
Howard Rhinehart
Melissa Billington
Robert Edelman
Samer S El-Kamary
Stephen Deitz
William Blackwelder
P2860
P304
P356
10.1038/MT.2011.235
P577
2011-11-08T00:00:00Z